brain spinal News
-
Unique mentoring project assists job seekers with disabilities
Diane Forsberg, sales and marketing manager at The Capital Grille in downtown Minneapolis, had an idea. She learned about a mentorship program offered by Darden Restaurants, parent company of The Capital Grille which gives people with disabilities valuable work skills. So, Forsberg contacted Courage Center to see if their clients would be interested in participating in a Disability Mentoring Day ...
-
Saneron and USF Patent Method for Umbilical Cord Blood Cell Use
Researchers at Saneron CCEL Therapeutics, Inc. of Tampa, Florida, (www.saneron-ccel.com) and the University of South Florida have received a patent relating to a method for obtaining and using umbilical cord blood cells from a donor or patient to provide neural cells for transplantation aimed at repairing a variety of neurodegenerative diseases of the brain and spinal cord, such as ...
-
Woolsey Pharmaceuticals Begins ALS Study
NEW YORK, December 13, 2021 — Woolsey Pharmaceuticals, a clinical-stage company developing treatments for neurodegenerative diseases, today announced it commenced a study of BRAVYL in Amyoptrophic Lateral Sclerosis (ALS) patients. ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. ALS is part of a wider group of disorders known as ...
-
Dicerna’s GalXC-Plus™ RNAi Technology Delivers Target Knockdown Across CNS and to Specific CNS Cell Types in Preclinical Studies
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced new data from preclinical studies of its GalXC-Plus™ RNAi technology demonstrating its potential to deliver deep and sustained messenger RNA (mRNA) knockdown against prespecified gene ...
-
Minneapolis Barber Lynn Lehman to receive Judd Jacobson memorial award
Disability can happen to any one, at any time. Lynn Lehman of Minneapolis knows this from personal experience. In April 1995, Lehman, was a busy single mom, and a barber/owner of Clipper Cuts on West Broadway in North Minneapolis. While driving to her mother's house to pick up her kids, a van in front of Lehman swerved to avoid a car driving the wrong way on 35W. Lehman's car was hit head-on by ...
-
CVS/pharmacy kicks off 9th annual ALS fundraising Campaign in stores nationwide
CVS/pharmacy has kicked-off its ninth annual in-store fundraising campaign to support the fight against amyotrophic lateral sclerosis (ALS). Since 2002, CVS/pharmacy has partnered with the ALS Therapy Alliance (ATA) to help advance ALS research. To date, CVS/pharmacy has raised more than $19 million in its stores--a single $1 donation at a time -- to support the funding of new clinical research ...
-
Woolsey Pharmaceuticals Receives Positive Opinion on Orphan Drug Application from the European Medicines Agency for the Treatment of ALS with BRAVYL
NEW YORK, NY – January 3, 2021 – Woolsey Pharmaceuticals, a repurposed therapeutics development company announced that the European Medicines Agency’s Committee for Orphan Medicinal Product has issued a positive opinion on the orphan drug application for the Company’s investigational drug, BRAVYL® (oral fasudil), for the treatment of Amyotrophic Lateral Sclerosis ...
-
Bacterial Meningitis Discussed in New Online Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of another online video to help educate people about issues that may impact their health. Their latest educational video discusses bacterial meningitis and the bacteria responsible for the infections. Meningitis is an infection of the protective membranes covering the brain and spinal cord. The condition can be ...
-
Endomedix Joins US Army Medical Research Groups in CRADA for Ocular Projectile Battlefield Trauma Project
Endomedix, Inc. announced today that it has entered into a Cooperative Research and Development Agreement or CRADA with the US. Army Institute of Surgical Research (USAISR) and the U.S. Army Medical Materiel Development Activity (USAMMDA). The CRADA will address a specific topic, “Ocular Projectile Battlefield Trauma Project”, an unsolved emergency medical treatment problem for ...
-
ALS research gets a $4.1 million boost from CVS/pharmacy fundraising Campaign
In just 21 days, CVS/pharmacy's ninth annual in-store fundraising campaign to support the fight against amyotrophic lateral sclerosis (ALS) brought in $4.1 million. The funds raised by the campaign will be donated to the Boston-based ALS Therapy Alliance (ATA) to support the funding of new clinical research aimed at developing new therapies for ALS patients and focused on the ultimate goal of ...
-
Lauren Sciences LLC awarded third grant for LAUR-301 from The ALS Association
New York, N.Y., April 11, 2018 -- Lauren Sciences LLC, the private New York biotechnology company developing transformative V-Smart® Nanomedicines for brain diseases, today announced the award of its third grant from The ALS Association. The ALS Association grant will support Lauren Sciences continued development of LAUR-301, its novel V-Smart® Nanomedicine for ALS (amyotrophic lateral ...
-
NeuroOne® Medical Technologies Corporation Releases Successful Long-Term Recording Test Data for its Novel Thin Film Platform Electrode Technology
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it successfully completed initial pre-clinical long-term testing of recording capabilities on its platform thin film electrode technology. In test ...
-
Kadimastem Expands R&D Program to Include Multiple Sclerosis
Ness Ziona, Science Park, May 18, 2022 - Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing a treatment for ALS and a potential cure for diabetes, is expanding its R&D activity with the exploration of developing a treatment for Multiple Sclerosis (MS). As part of this initiative, the company has signed a service agreement with Hadasit Medical Research Services ...
-
Endomedix, Inc. Announces Submission of Patent Application for Advanced Hemostat Technology
Endomedix, Inc., a developer of unique biosurgical products based on its natural biopolymer systems, today announced that it has submitted a comprehensive patent application to protect both its latest chemistry technology and also the design and function of the spray-on hydrogel hemostat that it is developing for brain and spine surgery indications. This patent application further expands and ...
-
Eikonoklastes Therapeutics and Forge Biologics Announce Viral Vector Contract Development and AAV Manufacturing Partnership
Eikonoklastes Therapeutics, a preclinical biotech company developing treatments for today’s most challenging diseases, and Forge Biologics, a gene therapy-focused contract development and manufacturing organization, today announced a manufacturing partnership that will advance Eikonoklastes’ AAV-based gene therapy, ET-101, into clinical trials for the treatment of patients with ...
-
Flowonix Receives FDA Approval to Market Prometra II Pump for use with Intrathecal Baclofen
Flowonix Medical, Inc. today announced United States Food and Drug Administration (FDA) approval to market the Prometra II Programmable Pump System for use with intrathecal baclofen. Flowonix introduced the Prometra II 40mL pump to the US market in November 2019, providing patients and clinicians a choice between 20 mL and 40 mL capacities when choosing an intrathecal pump delivery device. The ...
-
Lauren Sciences LLC research team at Ben-Gurion University awarded grant from The ALS Association to develop V-Smart Therapeutic for ALS
New York, N.Y., August 12, 2014 -- Lauren Sciences LLC, the private New York biotechnology company developing transformative V-Smart™ therapeutics, with its innovative V-Smart™ targeted drug delivery system, based upon its novel V-Smart™ nanovesicle platform technology, announced the award of a grant today from The ALS Association to its research team at Ben-Gurion University. ...
-
Lauren Sciences LLC awarded second grant for LAUR-301 from The ALS Association
New York, N.Y., April 19, 2016 -- Lauren Sciences LLC, private New York biotechnology company developing breakthrough V-SmartTM Nanomedicines for brain diseases, announced today award of second grant from The ALS Association. The ALS Association grant will support Lauren Sciences continued development of LAUR-301, its V-SmartTM Nanomedicine designed for ALS (amyotrophic lateral sclerosis), also ...
-
Hemostemix Announces Dr. Fraser C. Henderson Sr., MD, as Chief Medical Officer
Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV:HEM; OTC: HMTXF; FRA:2VFO) is pleased to announce the appointment of Dr. Fraser C. Henderson Sr., MD, as its Chief Medical Officer. Dr. Fraser C. Henderson Sr. is an exceptional neurological surgeon with extensive experience and expertise in all facets of neurosurgery and neurological science. Dr. Henderson is ...
-
Why ISC Users Choose HR Lubricating Jelly for Self-Catheterization
Millions of people rely on self-catheterization to empty their bladder due to conditions such as urinary bladder retention, spinal cord injury, traumatic brain injury, multiple sclerosis, and more. If you are an uncoated straight catheter user, a high-quality sterile catheter lubricant is an important addition to your catheter regimen to ensure a comfortable experience and reduce pain, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you